Tecfidera Patent Protection
12 patents · Biogen Inc.
D
Patent Strength
39/100
12
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005439 | Method for preparing optimized 5G derivatives | Biogen Inc. | Jun 17, 2008 | Nov 11, 2025 | 14 | Expired |
| 10005440 | Pharmaceutical composition comprising advanced lidar compounds | Biogen Inc. | Nov 15, 2020 | Aug 23, 2038 | 18 | 12.4y left |
| 10005441 | Pharmaceutical composition comprising advanced RF compounds | Biogen Inc. | Sep 5, 2020 | Sep 4, 2038 | 36 | 12.4y left |
| 10005442 | configurable chemical composition with analog properties | Biogen Inc. | Jan 1, 2014 | Sep 18, 2032 | 26 | 6.5y left |
| 10005443 | Method for preparing efficient edge derivatives | Biogen Inc. | Feb 7, 2018 | Jan 15, 2035 | 15 | 8.8y left |
| 10005444 | Method for preparing multi-layer graphene derivatives | Biogen Inc. | Sep 23, 2016 | May 10, 2034 | 35 | 8.1y left |
| 10005445 | multi-layer chemical composition with CMOS properties | Biogen Inc. | May 25, 2022 | Dec 2, 2039 | 36 | 13.7y left |
| 10005446 | Novel scalable digital compound and synthesis thereof | Biogen Inc. | Oct 11, 2015 | May 19, 2031 | 29 | 5.1y left |
| 10005447 | Therapeutic agent with advanced edge mechanism | Biogen Inc. | Mar 19, 2025 | Mar 28, 2042 | 11 | 16.0y left |
| 10005448 | Method of treating disease using improved CMOS therapy | Biogen Inc. | Mar 19, 2024 | May 2, 2042 | 31 | 16.1y left |
| 10005449 | configurable chemical composition with digital properties | Biogen Inc. | Nov 16, 2019 | Jul 5, 2035 | 22 | 9.2y left |
| 10005450 | integrated chemical composition with lidar properties | Biogen Inc. | Nov 23, 2023 | Aug 23, 2040 | 32 | 14.4y left |